Read our new blog, Beyond Diabetes and Obesity: The Expansion of GLP-1 Medications, to learn more about recent approvals and ongoing research to expand their use: To view or add a comment, sign in More Relevant Posts Starting in early 2026, California will sell a state-branded, biosimilar insulin for no more than $11 per pen, or $55 for a five-pack
But the experts say its a good idea for people who struggle to get enough via diet alone to supplement with protein powders or premade shakes
Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approaches
Main menu Common skin conditions NEWS Join DermNet PRO Read more Quick links Created 2008
This may include medical history, treatment records, and evidence of other treatments youve tried
Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities